LFCR Q1 2024 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

Q1 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$25M+3.4% YoY

Gross Profit

$3M11.1% margin

Operating Income

-$9M-35.1% margin

Net Income

-$11M-43.9% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$246M

Total Liabilities

$219M

Stockholders' Equity

$27M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$24M	+3.4%
Gross Profit	$3M	$6M	-54.4%
Operating Income	-$9M	-$3M	-163.1%
Net Income	-$11M	-$11M	+1.9%